X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home IPR Data Management

Use of Automation Fuelled By Growing Pharmaceutical Output

Content Team by Content Team
5th April 2024
in IPR Data Management, News

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

PMMI, which is the Association for Packaging and Processing Technologies, goes on to note that the forecasted expansion of the pharma machinery market happens to be driven by enhancements in tech, sustainability, automation as well as supply chain issues.

As per PMMI, in 2022, shipments pertaining to pharmaceutical machinery amounted to $1.1 billion, thereby representing 11% of the packaging machinery market, having a forecasted compound annual growth rate- CAGR of 7.8% by 2027. This growth trajectory happens to surpass that of numerous larger sectors, such as the food industry, which is anticipated to have a CAGR of 7.3%.

It is well to be noted that the pharmaceutical sector has recently gone on to announce certain high levels of production expansion investments. A major portion of the biggest pharmaceutical manufacturers have, as a matter of fact, announced capacity expansion in the billions, with most of the investment going toward expanding capacity across the state of North Carolina, says the director, custom research at PMMI, Rebecca Marquez. This has gone on to push the forecasted growth when it comes to packaging machine shipments to the pharmaceutical sector up for the years 2023 as well as 2024 as compared to other industries.

Marquez goes ahead and cites e-commerce and central pharmacies as major reasons for the growth. As e-commerce goes on to proliferate, there happens to be a trend toward multi-client order fulfillment centers. This spectrum will go on to represent a significant growth opportunity for packaging machine builders. Moreover, driving growth within the pharmaceutical machinery segment is the rise when it comes to central pharmacies, offering the ability for third parties to go ahead and fill prescriptions in the U.S. central pharmacies that happen to sit between retail pharmacies as well as wholesalers and serve multiple pharmacies. Moreover, central pharmacies are indeed being used in order to serve mail-order prescriptions within the growing e-commerce spectrum.

As far as the plans for 2024 are concerned, PMMI remarked that manufacturers have identified reliability/repeatability- 83% as their top priorities when it comes to assessing as well as comparing machines, and flexibility and faster changeover- 76% as crucial improvements for the next-generation machines. It is well to be noted that automating costs, labor, changing packaging formats because of sustainability requirements, and delays in acquiring parts happened to be all identified as issues for the industry in their respective domains. And finally, the latest data goes on to show the top five ways in which the OEMs as well as the suppliers can best help pharmaceutical packaging operations, with equipment precision as well as reliability going ahead and leading the way.

Previous Post

Drug Manufacturing Is Well-Positioned For A Potential Growth

Next Post

Innovation To Propel The Advanced Drug Delivery Sector

Related Posts

Merck to Acquire Verona
Drug Development

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

21st July 2025
ChiRhoClin LogiCare3PL Partners for Drug Distribution
News

ChiRhoClin, LogiCare3PL Partners for Drug Distribution

21st July 2025
Thermo Fisher and Sanofi Partners
Manufacturing

Thermo Fisher and Sanofi Partners for US Drug Manufacturing

21st July 2025
EMA Recommendations to Secure Anti D Immunoglobulins Supply
News

EMA Recommendations to Secure Anti-D Immunoglobulins Supply

15th July 2025
FDA Approves Oral Therapy for Treating Hereditary Angioedema
FDA Approvals

FDA Approves Oral Therapy for Treating Hereditary Angioedema

15th July 2025
WuXi Biologics and Virogen Bio partner to advance VG712
News

WuXi Biologics and Virogen Bio partner to advance VG712

19th June 2025
Next Post

Innovation To Propel The Advanced Drug Delivery Sector

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In